Lv0
0 积分 2025-07-03 加入
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial
10个月前
已完结
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
10个月前
已完结
Biology and evolution of poorly differentiated neuroendocrine tumors
10个月前
已完结
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma
10个月前
已完结
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade
10个月前
已完结
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
10个月前
已完结
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial
10个月前
已完结
Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial
10个月前
已完结
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
10个月前
已完结
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase II NeoCOAST-2 trial
10个月前
已完结
皖公网安备34019202002308
